A Phase II Study of MK-2206 in Patients with Incurable Adenoid Cystic Carcinoma (Alliance A091104)
- Citation:
- Cancer vol 130 (5) 702-712
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 13
- Parents:
- 2287
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24 CA196171, UG1CA232760, UG1CA233290, P30 CA008748, NIH R01 CA166978
- Corr. Author:
- Authors:
- Alan L. Ho Nathan R. Foster Shyamprasad Deraje Vasudeva Nora Katabi Cristina R. Antonescu Gary P. Frenette David G. Pfister Charles Erlichman Gary K. Schwartz
- Networks:
- COLUMBIA, LAPS-MN026, LAPS-NY016, NC002
- Study
- Alliance-A091104
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- adenoid cystic carcinoma, MYB, MK-2206, AKT, myb-nfib